miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
出版年份 2016 全文链接
标题
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
作者
关键词
-
出版物
Cell Death & Disease
Volume 7, Issue 6, Pages e2291-e2291
出版商
Springer Nature
发表日期
2016-06-30
DOI
10.1038/cddis.2016.194
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
- (2015) Yunhui Hu et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells
- (2015) Paul Zarogoulidis et al. CELLULAR SIGNALLING
- The Role of MicroRNAs in the Chemoresistance of Breast Cancer
- (2015) Jing Wang et al. DRUG DEVELOPMENT RESEARCH
- Modulatory role ofmiR-205in angiogenesis and progression of thyroid cancer
- (2015) Ali Salajegheh et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau–inactivated clear cell renal cell carcinoma
- (2015) Xin Ma et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
- (2015) Y Hu et al. Cell Death & Disease
- Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors
- (2015) Oncotarget
- Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
- (2014) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
- (2014) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations
- (2014) E. Traer et al. BLOOD
- MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis
- (2014) Chi-Hong Chao et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
- (2014) Peijing Zhang et al. Nature Communications
- miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
- (2013) Marzia Pennati et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins
- (2013) Yunhui Hu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
- (2013) Bisheng Zhou et al. CANCER LETTERS
- The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
- (2013) Y Zhou et al. CELL DEATH AND DIFFERENTIATION
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
- (2013) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
- (2013) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC
- (2013) Hideki Terai et al. MOLECULAR CANCER RESEARCH
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer
- (2013) J-Y Lee et al. ONCOGENE
- Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
- (2013) J. M. Balko et al. Cancer Discovery
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Loss of O6-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells
- (2012) Selina Raguz et al. BIOCHEMICAL PHARMACOLOGY
- Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer
- (2012) X. Wen et al. CELL PROLIFERATION
- Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue
- (2012) John Le Quesne et al. JOURNAL OF PATHOLOGY
- Synthesis of a Dual Functional Anti-MDR Tumor Agent PH II-7 with Elucidations of Anti-Tumor Effects and Mechanisms
- (2012) Ye Su et al. PLoS One
- Do predictive signatures really predict response to cancer chemotherapy?
- (2011) Piet Borst et al. CELL CYCLE
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
- (2010) Erik D. Wiklund et al. INTERNATIONAL JOURNAL OF CANCER
- Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells
- (2010) S Samuel et al. ONCOGENE
- The ups and downs of miR-205: Identifying the roles of miR-205 in mammary gland development and breast cancer
- (2010) Stephanie B. Greene et al. RNA Biology
- microRNA-205 Regulates HER3 in Human Breast Cancer
- (2009) M. V. Iorio et al. CANCER RESEARCH
- Suppression of cell growth and invasion by miR-205 in breast cancer
- (2009) Hailong Wu et al. CELL RESEARCH
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search